Skip to main content
Erschienen in: European Journal of Epidemiology 2/2015

01.02.2015 | CANCER

Is mammography screening history a predictor of future breast cancer risk?

verfasst von: Sune Bangsbøll Andersen, Sven Törnberg, Sini Kilpeläinen, My Von Euler-Chelpin, Sisse Helle Njor

Erschienen in: European Journal of Epidemiology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Inspired by the model by Walter and Day for risk of cervical cancer following negative screens, one might hypothesize that women in a mammography screening programme with a certain number of negative screens had a lower remaining breast cancer risk than that of women in general. We studied whether number of negative screens was a predictor for a low remaining breast cancer risk in women participating in the mammography screening programmes in Stockholm, Copenhagen and Funen. Data were collected from the mammography screening programmes in Stockholm, Sweden (1989–2012), Copenhagen, Denmark (1991–2009) and Funen, Denmark (1993–2009), and linked to the respective cancer registries. We calculated cumulative hazard rates for breast cancer in women in cohorts defined by age at entry and number of negative screens for the maximum follow-up period in each screening centre. For all centres and cohorts, the cumulative hazard were parallel for all number of negative screens, from after the time, when the women were scheduled to be invited for the next screen. This means that the remaining breast cancer risk is similar no matter how many negative screens a woman have had. Number of negative screens was not a predictor of a low remaining breast cancer risk in women participating in the mammography screening programmes in Stockholm, Sweden, Copenhagen and Funen, Denmark. The history of previous negative screens is therefore not suitable for personalisation of mammography screening.
Literatur
1.
Zurück zum Zitat Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86.CrossRef Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86.CrossRef
2.
Zurück zum Zitat Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, Von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol. 2008;19(4):614–22.CrossRefPubMed Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, Von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol. 2008;19(4):614–22.CrossRefPubMed
3.
Zurück zum Zitat Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86.CrossRefPubMed Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86.CrossRefPubMed
4.
Zurück zum Zitat Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111–30.CrossRefPubMed Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111–30.CrossRefPubMed
5.
Zurück zum Zitat Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res. 2012;14(1):R25.CrossRefPubMedCentralPubMed Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res. 2012;14(1):R25.CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer. 2011;104(10):1656–63.CrossRefPubMedCentralPubMed Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer. 2011;104(10):1656–63.CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008;358(26):2796–803.CrossRefPubMed Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008;358(26):2796–803.CrossRefPubMed
8.
Zurück zum Zitat Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10–20.CrossRefPubMedCentralPubMed Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10–20.CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Wu YY, Yen MF, Yu CP, Chen HH. Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors. Br J Cancer. 2013;108(11):2241–9.CrossRefPubMedCentralPubMed Wu YY, Yen MF, Yu CP, Chen HH. Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors. Br J Cancer. 2013;108(11):2241–9.CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Walter SD, Day NE. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983;118(6):865–86.PubMed Walter SD, Day NE. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983;118(6):865–86.PubMed
12.
Zurück zum Zitat von Euler-Chelpin M, Lynge E, Rebolj M. Register-based studies of cancer screening effects. Scand J Public Health. 2011;39(7 Suppl):158–64.CrossRef von Euler-Chelpin M, Lynge E, Rebolj M. Register-based studies of cancer screening effects. Scand J Public Health. 2011;39(7 Suppl):158–64.CrossRef
13.
Zurück zum Zitat O’Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, et al. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013;119(22):3959–67.CrossRefPubMedCentralPubMed O’Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, et al. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013;119(22):3959–67.CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat van Ravesteyn NT, Heijnsdijk EA, Draisma G, de Koning HJ. Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals. Br J Cancer. 2011;105(7):1082–8.CrossRefPubMedCentralPubMed van Ravesteyn NT, Heijnsdijk EA, Draisma G, de Koning HJ. Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals. Br J Cancer. 2011;105(7):1082–8.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Weiss NS, Etzioni R. Estimating the influence of rescreening interval on the benefits associated with cancer screening: approaches and limitations. Epidemiology. 2002;13(6):713–7.CrossRefPubMed Weiss NS, Etzioni R. Estimating the influence of rescreening interval on the benefits associated with cancer screening: approaches and limitations. Epidemiology. 2002;13(6):713–7.CrossRefPubMed
Metadaten
Titel
Is mammography screening history a predictor of future breast cancer risk?
verfasst von
Sune Bangsbøll Andersen
Sven Törnberg
Sini Kilpeläinen
My Von Euler-Chelpin
Sisse Helle Njor
Publikationsdatum
01.02.2015
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 2/2015
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-014-9972-6

Weitere Artikel der Ausgabe 2/2015

European Journal of Epidemiology 2/2015 Zur Ausgabe